Schoch Charles - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, Schoch Charles's relationship to Candel Therapeutics, Inc. (CADL) is Officer (Chief Financial Officer), and currently has 43,391 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CADL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Schoch Charles - Insider Non-Derivative Transactions of CADL Common Stock

Schoch Charles - Insider Non-Derivative Transactions at CADL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Acquisition -- (Common Stock)	5353	4.67	43391
Mar 18, 2025	Sell -- (Common Stock)	5000	8.83	38038
Jan 16, 2025	Sell -- (Common Stock)	9511	7.23	43038
Jan 9, 2025	Sell -- (Common Stock)	9971	8.22	52549
Jul 18, 2024	Sell -- (Common Stock)	9884	6.47	62520
Jul 12, 2024	Sell -- (Common Stock)	8897	5.97	72404